Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:TG 18:1_22:1_26:1)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003760 AN006174 Untargeted lipidomics of combination gemcitabine/paclitaxel attenuated (CombAT) PDAC cells Pancreas Human Cancer Victor Chang Cardiac Research Institute LC-MS
ST003758 AN006170 Untargeted lipidomics of gemcitabine-resistant cells Pancreas Human Cancer Victor Chang Cardiac Research Institute LC-MS
ST002967 AN004875 Lipidomics study of FASN inhibition in HT-29 and HCT 116 spheroids Cultured cells Human Cancer Ohio State University LC-MS
  logo